Mordechai Shtalrid

1.3k total citations
36 papers, 851 citations indexed

About

Mordechai Shtalrid is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Mordechai Shtalrid has authored 36 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 20 papers in Genetics and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Mordechai Shtalrid's work include Chronic Lymphocytic Leukemia Research (20 papers), Lymphoma Diagnosis and Treatment (10 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Mordechai Shtalrid is often cited by papers focused on Chronic Lymphocytic Leukemia Research (20 papers), Lymphoma Diagnosis and Treatment (10 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Mordechai Shtalrid collaborates with scholars based in Israel, United States and United Kingdom. Mordechai Shtalrid's co-authors include Alain Berrébi, Lev Shvidel, José M. Trujillo, Razelle Kurzrock, Jordan U. Gutterman, Mark Blick, Miloslav Beran, William S. Kloetzer, Abraham Klepfish and Ami Schattner and has published in prestigious journals such as Nature, Blood and The American Journal of Medicine.

In The Last Decade

Mordechai Shtalrid

36 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mordechai Shtalrid Israel 15 488 412 230 178 171 36 851
Barbara Crescenzi Italy 18 476 1.0× 235 0.6× 161 0.7× 144 0.8× 162 0.9× 55 1.0k
H van Kamp Netherlands 15 483 1.0× 146 0.4× 136 0.6× 159 0.9× 110 0.6× 25 883
Silvana Capalbo Italy 15 289 0.6× 271 0.7× 143 0.6× 179 1.0× 46 0.3× 37 669
Odile Maarek France 13 645 1.3× 411 1.0× 159 0.7× 120 0.7× 120 0.7× 24 1.0k
BA Zehnbauer United States 11 830 1.7× 402 1.0× 71 0.3× 164 0.9× 182 1.1× 14 1.1k
D Sainty France 15 523 1.1× 194 0.5× 115 0.5× 163 0.9× 147 0.9× 38 764
Ilana Zalcberg Brazil 14 297 0.6× 216 0.5× 196 0.9× 132 0.7× 70 0.4× 53 739
Anna Jankowska United States 15 494 1.0× 324 0.8× 100 0.4× 188 1.1× 66 0.4× 27 939
G.H. Borgström Finland 16 587 1.2× 284 0.7× 96 0.4× 65 0.4× 348 2.0× 24 919
Gutterman Ju United States 14 287 0.6× 302 0.7× 125 0.5× 284 1.6× 84 0.5× 24 719

Countries citing papers authored by Mordechai Shtalrid

Since Specialization
Citations

This map shows the geographic impact of Mordechai Shtalrid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mordechai Shtalrid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mordechai Shtalrid more than expected).

Fields of papers citing papers by Mordechai Shtalrid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mordechai Shtalrid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mordechai Shtalrid. The network helps show where Mordechai Shtalrid may publish in the future.

Co-authorship network of co-authors of Mordechai Shtalrid

This figure shows the co-authorship network connecting the top 25 collaborators of Mordechai Shtalrid. A scholar is included among the top collaborators of Mordechai Shtalrid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mordechai Shtalrid. Mordechai Shtalrid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Haran, Michal, et al.. (2012). Can a rare form of myasthenia gravis shed additional light on disease mechanisms?. Clinical Neurology and Neurosurgery. 115(5). 562–566. 11 indexed citations
3.
Filanovsky, Kalman, et al.. (2009). The May‐Hegglin anomaly. European Journal Of Haematology. 83(4). 390–390. 1 indexed citations
5.
Shvidel, Lev, et al.. (2006). Vincristine-loaded platelet infusion for treatment of refractory autoimmune hemolytic anemia and chronic immune thrombocytopenia: Rethinking old cures. American Journal of Hematology. 81(6). 423–425. 17 indexed citations
6.
Shtalrid, Mordechai, et al.. (2006). Post-transfusion purpura: a challenging diagnosis.. PubMed. 8(10). 672–4. 29 indexed citations
7.
Shtalrid, Mordechai, Lev Shvidel, Roman Korenfeld, et al.. (2005). HTLV-1 associated adult T-cell leukemia/lymphoma in Israel: report of two patients of Romanian origin.. PubMed. 90(3). ECR13–ECR13. 8 indexed citations
8.
Shvidel, Lev, et al.. (2003). Acute basophilic leukaemia: eight unsuspected new cases diagnosed by electron microscopy. British Journal of Haematology. 120(5). 774–781. 13 indexed citations
9.
Shvidel, Lev, Mordechai Shtalrid, Osnat Bairey, et al.. (2003). Conventional Dose Fludarabine-based Regimens are Effective but have Excessive Toxicity in Elderly Patients with Refractory Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 44(11). 1947–1950. 37 indexed citations
11.
Shtalrid, Mordechai, et al.. (2002). New sporadic case of congenital dyserythropoietic anemia type III in an aged woman: detailed description of ultrastructural findings. American Journal of Hematology. 70(1). 72–76. 9 indexed citations
12.
Klepfish, Abraham, Ronit Sarid, Mordechai Shtalrid, et al.. (2001). Primary Effusion Lymphoma (PEL) in HIV-Negative Patients - a Distinct Clinical Entity. Leukemia & lymphoma. 41(3-4). 439–443. 67 indexed citations
14.
Shimoni, Avichai, et al.. (1998). Prolymphocytic transformation of B‐chronic lymphocytic leukemia presenting as malignant ascites and pleural effusion. American Journal of Hematology. 59(4). 316–318. 1 indexed citations
15.
Shtalrid, Mordechai, et al.. (1998). Ultrastructural characteristics and lysozyme content in hypergranular and variant type of acute promyelocytic leukaemia. British Journal of Haematology. 103(3). 729–739. 7 indexed citations
16.
Shvidel, Lev, et al.. (1995). Complex IgA Gammopathy in Gaucher's Disease. Leukemia & lymphoma. 20(1-2). 165–168. 14 indexed citations
17.
Berrébi, Alain, et al.. (1990). Further characterization of prolymphocytic leukemia cells as a tumor of activated B cells. American Journal of Hematology. 34(3). 181–185. 11 indexed citations
18.
Terjanian, Terenig, Mark Blick, Mordechai Shtalrid, et al.. (1989). Philadelphia chromosome without breakpoint cluster region rearrangement in a case of Lennert's lymphoma of suppressor phenotype. Hematological Oncology. 7(3). 189–194. 5 indexed citations
19.
Kantarjian, Hagop M., Mordechai Shtalrid, Razelle Kurzrock, et al.. (1988). Significance and correlations of molecular analysis results in patients with philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. The American Journal of Medicine. 85(5). 639–644. 33 indexed citations
20.
Kurzrock, Razelle, Mordechai Shtalrid, J. U. Gutterman, et al.. (1987). Molecular analysis of chromosome 22 breakpoints in adult Philadelphia-positive acute lymphoblastic leukaemia. British Journal of Haematology. 67(1). 55–59. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026